Pharmacy-Grade Peptides.

A pentadecapeptide composed of 15 amino acids. Widely studied for its role in tissue repair, gut health, and angiogenesis research.

A glucagon-like peptide-1 (GLP-1) receptor agonist analog. High-demand research compound studied for metabolic and glycemic regulation.

An ACTH-derived heptapeptide. Studied for neuroprotective, cognitive, and neurological applications in research settings.

A synthetic version of the naturally occurring thymosin beta-4 peptide. Studied for its role in actin regulation and tissue repair.

A selective growth hormone secretagogue and ghrelin receptor agonist. Studied for GH release mechanisms and metabolic research.

A synthetic analog of the immunomodulatory peptide tuftsin. Studied for anxiolytic and nootropic effects in research models.

A melanocortin receptor agonist derived from alpha-MSH. Studied for its effects on sexual function and melanocortin pathways.

A powerful recovery and regeneration stack combining BPC-157 and TB-500. Studied for accelerated tissue repair, angiogenesis, and musculoskeletal healing research.

A comprehensive anti-inflammatory and repair stack. Combines KPV, BPC-157, TB-500, and GHK-Cu for broad-spectrum tissue regeneration, immune modulation, and skin repair research.

A critical coenzyme found in all living cells. Widely studied for cellular energy metabolism, DNA repair, sirtuin activation, and longevity research.

A skin, hair, and tissue rejuvenation stack combining BPC-157, TB-500, and GHK-Cu. Studied for collagen synthesis, wound healing, angiogenesis, and anti-aging research.

A hexapeptide GH secretagogue that stimulates ghrelin receptors. Widely studied for growth hormone release mechanisms and appetite regulation research.

A synthetic hexapeptide GH secretagogue with potent GH-releasing activity. Studied for pituitary function and growth hormone axis research.

A long-acting GHRH analog with a drug affinity complex (DAC) for extended half-life. Studied for sustained GH and IGF-1 elevation in research models.

A modified GHRH fragment without the drug affinity complex. Studied for short-acting GH pulse research and pulsatile secretion models.

The biologically active fragment of GHRH consisting of the first 29 amino acids. Studied for its role in stimulating pituitary GH secretion.

A potent synthetic hexapeptide GH secretagogue. Studied for GH release, cardiac function, and ghrelin receptor activity in research models.

A dual GIP and GLP-1 receptor agonist. Among the most studied metabolic peptides in current research for glycemic control and body composition.

A triple agonist targeting GLP-1, GIP, and glucagon receptors. Studied for its effects on energy expenditure, metabolic rate, and body composition.

A modified fragment of human growth hormone (hGH176-191). Studied for lipolytic activity and fat metabolism without the proliferative effects of full hGH.

A stabilized GHRH analog studied for visceral adipose tissue reduction and metabolic effects. Widely referenced in HIV-associated lipodystrophy research.

The C-terminal decapeptide of kisspeptin. A potent activator of GnRH neurons studied for reproductive endocrinology and HPG axis regulation.

A cyclic lactam analog of alpha-MSH. Studied for melanocortin receptor activation, pigmentation, and sexual function research.

A mitochondrial-derived peptide that regulates metabolic homeostasis. Studied for insulin sensitivity, exercise mimicry, and longevity pathways.

A mitochondria-targeted tetrapeptide. Studied for cardioprotection, mitochondrial membrane stabilization, and oxidative stress reduction.

A naturally occurring copper-binding tripeptide. Studied for wound healing, collagen synthesis, anti-inflammatory activity, and skin regeneration research.

The C-terminal tripeptide of alpha-MSH with potent anti-inflammatory properties. Studied for gut inflammation, IBD models, and melanocortin receptor research.

A neuropeptide studied for sleep regulation, stress response modulation, and neuroendocrine function. Widely referenced in sleep research literature.